Comparison - HCAT - NASDAQ

Weiss Ratings	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Fair
Efficiency Index	Very Weak
Solvency Index	Excellent
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	1.44

Price History	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-9.07%
30-Day Total Return	-27.00%
60-Day Total Return	-48.69%
90-Day Total Return	-48.88%
Year to Date Total Return	-43.97%
1-Year Total Return	-49.51%
2-Year Total Return	-64.69%
3-Year Total Return	-80.12%
5-Year Total Return	-82.43%
52-Week High % Change	-52.06%
52-Week Low % Change	17.82%

Price	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$9.24
52-Week Low Price	$3.76
52-Week Low Price (Date)	Feb 27, 2025
52-Week High Price (Date)	Dec 02, 2024

Valuation	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	311.03M
Enterprise Value	321.30M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-1.15
Earnings Per Share Growth	-44.95%
Price/Earnings To Growth	--
Price/Sales (TTM)	0.90
Price/Book (Q)	0.78
Enterprise Value/Revenue (TTM)	1.05
Price	$4.11
Enterprise Value/EBITDA (TTM)	-12.67
Enterprise Value/EBIT	-5.63
Market Cap Category	Small Cap

Dividends and Shares	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	62.38M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	(801) 708-6800
Address	10897 South River Front Parkway South Jordan, UT 84095
Website	www.healthcatalyst.com
Country	United States
Year Founded	2008

Profitability	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-18.62%
Profit Margin	-22.66%

Management Effectiveness	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-4.57%
Return on Equity	--

Income Statement	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	306.58M
Total Revenue (TTM)	306.58M
Revenue Per Share	$4.92
Gross Profit (TTM)	141.79M
EBITDA (TTM)	-25.37M
EBIT (TTM)	-57.10M
Net Income (TTM)	-69.50M
Net Income Avl. to Common (TTM)	-69.50M
Total Revenue Growth (Q YOY)	6.02%
Earnings Growth (Q YOY)	31.80%
EPS Diluted (TTM)	-1.15
EPS Diluted Growth (Q YOY)	37.16%

Balance Sheet	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	392.00M
Cash Per Share (Q)	$6.28
Total Current Assets (Q)	465.65M
Total Preferred Equity (Q)	--
Total Equity (Q)	365.21M
Current Ratio (Q)	1.429
Book Value Per Share (Q)	$5.70
Total Assets (Q)	858.93M
Total Current Liabilities (Q)	325.85M
Total Debt (Q)	402.27M
Total Liabilities (Q)	493.72M
Total Common Equity (Q)	365.21M

Cash Flow	HCAT - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-22.90M
Cash from Financing (TTM)	151.75M
Net Change in Cash (TTM)	143.37M
Levered Free Cash Flow (TTM)	29.45M
Cash from Operations (TTM)	14.56M